DK1606418T3 - Fremgangsmåder til diagnosticering og behandling af epilepsi - Google Patents

Fremgangsmåder til diagnosticering og behandling af epilepsi

Info

Publication number
DK1606418T3
DK1606418T3 DK04718885.9T DK04718885T DK1606418T3 DK 1606418 T3 DK1606418 T3 DK 1606418T3 DK 04718885 T DK04718885 T DK 04718885T DK 1606418 T3 DK1606418 T3 DK 1606418T3
Authority
DK
Denmark
Prior art keywords
diagnosing
methods
treating epilepsy
epilepsy
treating
Prior art date
Application number
DK04718885.9T
Other languages
English (en)
Inventor
Steven Petrou
Samuel Frank Berkovic
Ingrid Eileen Scheffer
Original Assignee
Bionomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionomics Ltd filed Critical Bionomics Ltd
Application granted granted Critical
Publication of DK1606418T3 publication Critical patent/DK1606418T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK04718885.9T 2003-03-27 2004-03-10 Fremgangsmåder til diagnosticering og behandling af epilepsi DK1606418T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003901425A AU2003901425A0 (en) 2003-03-27 2003-03-27 A diagnostic method for epilepsy
PCT/AU2004/000295 WO2004085674A1 (en) 2003-03-27 2004-03-10 Methods for the diagnosis and treatment of epilepsy

Publications (1)

Publication Number Publication Date
DK1606418T3 true DK1606418T3 (da) 2014-07-14

Family

ID=31500468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04718885.9T DK1606418T3 (da) 2003-03-27 2004-03-10 Fremgangsmåder til diagnosticering og behandling af epilepsi

Country Status (9)

Country Link
US (2) US7723027B2 (da)
EP (1) EP1606418B1 (da)
JP (1) JP2006524490A (da)
AU (1) AU2003901425A0 (da)
CA (1) CA2520271C (da)
DK (1) DK1606418T3 (da)
ES (1) ES2478624T3 (da)
NZ (1) NZ542202A (da)
WO (1) WO2004085674A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR220300A0 (en) 2000-12-20 2001-01-25 Bionomics Limited New epilepsy gene
NZ542048A (en) 2001-07-18 2008-04-30 Bionomics Ltd Mutations in ion channels
AU2003904154A0 (en) 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
US7709225B2 (en) * 2001-07-18 2010-05-04 Bionomics Limited Nucleic acids encoding mutations in sodium channels related to epilepsy
AU2003901425A0 (en) 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy
WO2006133508A1 (en) * 2005-06-16 2006-12-21 Bionomics Limited Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
US20090304747A1 (en) * 2006-05-16 2009-12-10 Mayo Foundation For Medical Education And Research Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
WO2011093393A1 (ja) 2010-01-29 2011-08-04 国立大学法人岡山大学 Dravet症候群の発症可能性の判定方法およびその利用
WO2011163499A2 (en) 2010-06-23 2011-12-29 Opko Curna, Llc Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
AR106530A1 (es) * 2015-10-30 2018-01-24 Ptc Therapeutics Inc Métodos para tratar epilepsia
WO2019224864A1 (ja) * 2018-05-21 2019-11-28 国立研究開発法人理化学研究所 Ｓｃｎ１ａ遺伝子の発現増強法とそれによるドラベ症候群の治療法
CN113197585B (zh) * 2021-04-01 2022-02-18 燕山大学 一种神经肌肉信息交互模型构建及参数辨识优化方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4971903A (en) * 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
NO175199C (no) 1991-12-05 1994-09-14 Kvaerner Fjellstrand As Flerskrogfartöy
US5646040A (en) 1995-06-30 1997-07-08 Millennium Pharmaceutical, Inc. Mammalian tub gene
US6331614B1 (en) * 1998-12-23 2001-12-18 Myriad Genetics, Inc. Human CDC14A gene
WO2001038564A2 (en) * 1999-11-26 2001-05-31 Mcgill University Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
US6331573B1 (en) * 2000-02-29 2001-12-18 Chevron U.S.A. Inc. Increased liquid sensitivity during fischer-tropsch synthesis by olefin incorporation
AUPQ749100A0 (en) 2000-05-12 2000-06-08 Bionomics Limited New epilespy gene
US7157569B2 (en) 2000-06-20 2007-01-02 Bionomics Limited Mutation associated with epilepsy
AUPQ882600A0 (en) 2000-07-18 2000-08-10 Bionomics Limited Mutations in ion channels
AUPR220300A0 (en) * 2000-12-20 2001-01-25 Bionomics Limited New epilepsy gene
NZ542048A (en) * 2001-07-18 2008-04-30 Bionomics Ltd Mutations in ion channels
AU2003904154A0 (en) * 2003-08-07 2003-08-21 Bionomics Limited Mutations in ion channels
US7709225B2 (en) * 2001-07-18 2010-05-04 Bionomics Limited Nucleic acids encoding mutations in sodium channels related to epilepsy
US7282336B2 (en) * 2001-07-18 2007-10-16 Bionomics Limited Method of diagnosing epilepsy
EP1474176A4 (en) * 2001-11-26 2005-06-15 Bristol Myers Squibb Co HUMAN G PROTEIN-COUPLED RECEPTOR, HGPRBMY31, VARIANTS AND METHODS OF USING THE SAME
AU2003901425A0 (en) * 2003-03-27 2003-04-10 Bionomics Limited A diagnostic method for epilepsy
WO2006133508A1 (en) * 2005-06-16 2006-12-21 Bionomics Limited Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene

Also Published As

Publication number Publication date
EP1606418B1 (en) 2014-05-07
CA2520271C (en) 2014-09-23
US20100203548A1 (en) 2010-08-12
EP1606418A1 (en) 2005-12-21
JP2006524490A (ja) 2006-11-02
CA2520271A1 (en) 2004-10-07
WO2004085674A1 (en) 2004-10-07
US8288096B2 (en) 2012-10-16
US7723027B2 (en) 2010-05-25
AU2003901425A0 (en) 2003-04-10
EP1606418A4 (en) 2006-11-22
ES2478624T3 (es) 2014-07-22
US20040229257A1 (en) 2004-11-18
NZ542202A (en) 2009-07-31

Similar Documents

Publication Publication Date Title
NO20040640L (no) Anordning og fremgangsmate
IS8204A (is) Tæki og aðferð til að hluta niður
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
BRPI0400713B1 (pt) aparelho de filtro e mÉtodo associado.
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
IS8420A (is) Aðferð fyrir örugga auðkenningu
DK1725253T3 (da) Medikamenter og fremgangsmåder til behandling af hovedpine
DK1608445T3 (da) Konfigurationer og fremgangsmåder til kulstofindfangning
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
NO20053896D0 (no) System og fremgangsmate for automatisert malretting
DE602004012078D1 (de) Dichtungsvorrichtungund diese verwendendes dichtungsverfahren
DE602005001520D1 (de) Zeiteinstellungssystem und Zeiteinstellungsverfahren
DK1611890T3 (da) Fremgangsmåde til evaluering og behandling af cancer
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
IS8489A (is) Umritunarstillar og aðferðir þeirra
NO20043002L (no) Anordning og fremgangsmate til diskontinuerlig polykondensasjon
DK1606418T3 (da) Fremgangsmåder til diagnosticering og behandling af epilepsi
NO20050503D0 (no) Fremgangsmate og anordning
DK1879908T3 (da) Immunoglobulinfraktion og fremgangsmåde hertil
DE602006007889D1 (de) Belichtungsverfahren und -vorrichtung
NO20044012D0 (no) Fremgangsmate og et system
ATE368907T1 (de) Authentifizierungsverfahren und -vorrichtung
DK1791423T3 (da) Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande
NO322006B2 (no) Anordning og fremgangsmåte for brønnintervenering
DK1662867T3 (da) Insekticid-forbindelser og fremgangsmåder til valg deraf